| Dr Christopher Daniel Muncie, DO | |
|
3045 S National Ave Ste 110, Springfield, MO 65804-4247 | |
| (417) 820-5610 | |
| Not Available |
| Full Name | Dr Christopher Daniel Muncie |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 8 Years |
| Location | 3045 S National Ave Ste 110, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003260985 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Springfield | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Springfield Communities | 7416865845 | 922 |
News Archive
Elan Corporation, plc announced that at yesterday's meeting of the Elan Board of Directors, the Board unanimously accepted a report prepared by the United States law firm of McKenna Long & Aldridge, LLP based upon a review it conducted. McKenna Long, serving as independent counsel to the Board, reviewed a number of matters brought to the Board's attention by certain Directors.
The inner-city neighbourhood in which someone lives may affect his or her risk of developing or dying from cardiovascular disease, a new research paper suggests.
Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.
The Australian Scleroderma Interest Group has derived a screening algorithm for pulmonary arterial hypertension in patients with systemic sclerosis that saves costs by reducing the need for transthoracic echocardiography and right heart catheterisation.
› Verified 9 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245277631 PECOS PAC ID: 7416865845 Enrollment ID: O20031104000060 |
News Archive
Elan Corporation, plc announced that at yesterday's meeting of the Elan Board of Directors, the Board unanimously accepted a report prepared by the United States law firm of McKenna Long & Aldridge, LLP based upon a review it conducted. McKenna Long, serving as independent counsel to the Board, reviewed a number of matters brought to the Board's attention by certain Directors.
The inner-city neighbourhood in which someone lives may affect his or her risk of developing or dying from cardiovascular disease, a new research paper suggests.
Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.
The Australian Scleroderma Interest Group has derived a screening algorithm for pulmonary arterial hypertension in patients with systemic sclerosis that saves costs by reducing the need for transthoracic echocardiography and right heart catheterisation.
› Verified 9 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972771657 PECOS PAC ID: 7416865845 Enrollment ID: O20031218000354 |
News Archive
Elan Corporation, plc announced that at yesterday's meeting of the Elan Board of Directors, the Board unanimously accepted a report prepared by the United States law firm of McKenna Long & Aldridge, LLP based upon a review it conducted. McKenna Long, serving as independent counsel to the Board, reviewed a number of matters brought to the Board's attention by certain Directors.
The inner-city neighbourhood in which someone lives may affect his or her risk of developing or dying from cardiovascular disease, a new research paper suggests.
Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.
The Australian Scleroderma Interest Group has derived a screening algorithm for pulmonary arterial hypertension in patients with systemic sclerosis that saves costs by reducing the need for transthoracic echocardiography and right heart catheterisation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Daniel Muncie, DO 3045 S National Ave Ste 110, Springfield, MO 65804-4247 Ph: (417) 820-5610 | Dr Christopher Daniel Muncie, DO 3045 S National Ave Ste 110, Springfield, MO 65804-4247 Ph: (417) 820-5610 |
News Archive
Elan Corporation, plc announced that at yesterday's meeting of the Elan Board of Directors, the Board unanimously accepted a report prepared by the United States law firm of McKenna Long & Aldridge, LLP based upon a review it conducted. McKenna Long, serving as independent counsel to the Board, reviewed a number of matters brought to the Board's attention by certain Directors.
The inner-city neighbourhood in which someone lives may affect his or her risk of developing or dying from cardiovascular disease, a new research paper suggests.
Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.
The Australian Scleroderma Interest Group has derived a screening algorithm for pulmonary arterial hypertension in patients with systemic sclerosis that saves costs by reducing the need for transthoracic echocardiography and right heart catheterisation.
› Verified 9 days ago
Dr. John Scott Swango, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1229 E Seminole St, Springfield, MO 65804 Phone: 417-820-5610 Fax: 417-820-5589 | |
Joshua Brandon, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3555 S National Ave, Springfield, MO 65807 Phone: 417-875-3800 | |
Dr. Victoria D. Kubik, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1229 E Seminole St, Springfield, MO 65804 Phone: 417-820-5610 Fax: 417-820-5588 | |
Roy W Holand, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1001 E Primrose St, Springfield, MO 65807 Phone: 417-875-3000 | |
Ken J. Carpenter, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3555 S National Ave, Springfield, MO 65807 Phone: 417-875-3800 Fax: 417-875-3177 | |
Dr. Vela Chebolu, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3555 S National Ave, Springfield, MO 65807 Phone: 417-875-3000 |